Table 1 Characteristics of the participants at baseline
Total (N = 1214) | Male (N = 678) | Female (N = 536) | P | |
|---|---|---|---|---|
Female, n(%) | 536(44.15) | - | - | < 0.001 |
Age(year), [M(IOR)] | 50(40 to 58) | 51(41 to 59) | 48(39 to 56) | < 0.001 |
BMI(kg/m2), [M(IOR)] | 23.5(21.5 to 25.7) | 24.7(23.2 to 26.8) | 21.7(20.3 to 23.5) | < 0.001 |
Hypertension, n(%) | 181(14.91) | 137(20.21) | 44(8.21) | < 0.001 |
Dyslipidaemia, n(%) | 329(27.10) | 230(33.92) | 99(18.47) | < 0.001 |
SBP(mmHg), [M(IOR)] | 128(118 to 139) | 132(122 to 142) | 123(114 to 134) | < 0.001 |
DBP(mmHg), [M(IOR)] | 78(71 to 84) | 82(76 to 87) | 73(67 to 79) | < 0.001 |
FPG(mmol/L), [M(IOR)] | 5.13(4.82 to 5.47) | 5.20(4.88 to 5.58) | 5.07(4.76 to 5.34) | < 0.001 |
HbA1c(%), [M(IOR)] | 5.5(5.3 to 5.8) | 5.5(5.3 to 5.8) | 5.5(5.0 to 5.6) | < 0.001 |
TG(mmol/L), [M(IOR)] | 1.17(0.84 to 1.68) | 1.35(0.98 to 1.85) | 1.00(0.74 to 1.42) | < 0.001 |
TC(mmol/L), [M(IOR)] | 4.79(4.26 to 5.45) | 4.75(4.15 to 5.37) | 4.89(4.33 to 5.52) | 0.002 |
HDL-C(mmol/L), [M(IOR)] | 1.38(1.15 to 1.67) | 1.23(1.08 to 1.44) | 1.62(1.37 to 1.86) | < 0.001 |
LDL-C(mmol/L), [M(IOR)] | 3.04(2.55 to 3.56) | 3.08(2.56 to 3.57) | 3.00(2.55 to 3.54) | 0.387 |
TyG-BMI, [M(IOR)] | 201.24(176.78 to 223.82) | 214.74(196.82 to 235.35) | 179.63(164.69 to 202.19) | < 0.001 |
LHR, [M(IOR)] | 1.37(1.02 to 1.80) | 1.58(1.20 to 1.98) | 1.13(0.88 to 1.47) | < 0.001 |
MHR, [M(IOR)] | 0.29(0.21 to 0.39) | 0.35(0.27 to 0.46) | 0.22(0.17 to 0.29) | < 0.001 |
NHR, [M(IOR)] | 2.21(1.62 to 3.02) | 2.60(1.98 to 3.45) | 1.81(1.36 to 2.47) | < 0.001 |
Incidence rate(100 person-years) | 3.55 | 3.47 | 3.65 | 0.824 |